Overview
Guoxiang Liu practices practicing medicine in Harbin, China.
Their clinical expertise encompasses Human Papillomavirus Infection, Cervical Cancer, Colorectal Cancer, and Lung Cancer.
They are actively involved in clinical research, co-authoring 39 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Guoxiang Y. Liu
Is Guoxiang Y. Liu a top-rated expert for Human Papillomavirus Infection?
MediFind is an objective health platform that identifies experts based on real-world data. Guoxiang Y. Liu is classified as an Experienced expert for Human Papillomavirus Infection, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Guoxiang Y. Liu participate in research or clinical trials?
Yes. Guoxiang Y. Liu has published 39 articles and abstracts on conditions like Human Papillomavirus Infection. You can view a list of Guoxiang Y. Liu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Cervical CancerLiu isExperienced. Learn about Cervical Cancer.
- Colorectal CancerLiu isExperienced. Learn about Colorectal Cancer.
- Human Papillomavirus Infection
- Lung CancerLiu isExperienced. Learn about Lung Cancer.